Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,035 | 58,535 | 58,176 | 61,688 | 165,753 |
| Marketable Securities | 229,761 | 312,166 | 508,675 | 388,557 | 387,129 |
| Receivables | 80,134 | 27,116 | 21,179 | 16,646 | 15,914 |
| Inventories | 5,875 | 6,200 | 9,410 | 4,523 | 7,313 |
| Other current assets | 0 | 0 | 0 | 2,990 | 0 |
| TOTAL | $437,565 | $416,702 | $616,775 | $486,437 | $582,827 |
| Non-Current Assets | |||||
| PPE Net | 4,022 | 5,336 | 7,479 | 9,049 | 11,106 |
| Intangibles | 113,868 | 103,974 | 104,443 | 97,073 | 148,435 |
| Other Non-Current Assets | 49,736 | 68,113 | 60,216 | 80,026 | 34,265 |
| TOTAL | $167,626 | $177,423 | $172,138 | $186,148 | $193,806 |
| Total Assets | $605,191 | $594,125 | $788,913 | $672,585 | $776,633 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,800 | 23,534 | 41,675 | 17,290 | 15,144 |
| Accrued Expenses | 126,035 | 86,028 | 118,991 | 95,742 | 75,180 |
| Other current liabilities | 3,194 | 17,106 | 5,237 | 5,722 | 13,588 |
| TOTAL | $159,904 | $200,751 | $177,908 | $142,163 | $124,088 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 7,096 | 11,976 | 16,268 |
| Other Non-Current Liabilities | 330,459 | 334,297 | 410,195 | 476,640 | 330,054 |
| TOTAL | $330,459 | $334,297 | $410,195 | $487,571 | $350,433 |
| Total Liabilities | $490,363 | $535,048 | $588,103 | $629,734 | $474,521 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,242 | 88,740 | 76,098 | 64,745 | 63,212 |
| Common Shares | 9 | 9 | 7 | 6 | 6 |
| Retained earnings | -1,472,713 | -1,447,167 | -1,125,622 | -1,014,223 | -765,966 |
| Other shareholders' equity | -1,189 | -80 | -1,456 | -2,907 | -562 |
| TOTAL | $114,828 | $59,077 | $200,810 | $42,851 | $302,112 |
| Total Liabilities And Equity | $605,191 | $594,125 | $788,913 | $672,585 | $776,633 |